CLINICAL MICROBIOLOGY REVIEWS, July 2003, p. 463–496 0893-8512/03/$08.00 0 DOI: 10.1128/CMR.16.3.463–496.2003 Copyright © 2003, American Society for Microbiology. All…

1.Open Source Drug DiscoveryCSIR-led Team India Consortium with Global Partnership Affordable Healthcare for All Cheminformatics and Open Source Drug Discovery: acase study…

1. Studies on the implications of PE class proteins of Mycobacterium tuberculosis as determinants of pathogenicity and Immuno-prophylaxisSameer Tiwari Division of MicrobiologyL/O/G/O…

1. Molecular modeling and in silico characterization of Mycobacterium tuberculosis TlyA: Possible misannotation of this tubercle bacilli-hemolysin Yakovlev Pavel St-Petersburg…

Title: Efflux as mechanism for drug resistance in Mycobacterium tuberculosis Authors: Pedro Eduardo Almeida da Silva1, Andrea Von Groll1,2, Anandi Martin2 and Juan Carlos…

Slide 1BCG and Other Candidate Vaccines for Tuberculosis RajKumar Kayal Guwahati Slide 2 Tuberculosis: Global Burden One third of world’s population infected with M. tuberculosis…

IâM NOT HOMELESS I AM NOT HOMELESS CSTE June 2013 Dee Pritschet, TB Controller â North Dakota Department of Health Shawn McBride, Epidemiologist â North Dakota Department…

Functional discoveries from a structural genomics approach to TB Ted Baker Palmerston North - centre of the Universe Guy born and grew up here Palmerston North Oxford York…

CLINICAL MICROBIOLOGY REVIEWS, July 2003, p. 463–496 Vol. 16, No. 3 0893-8512/03/$08.00�0 DOI: 10.1128/CMR.16.3.463–496.2003 Copyright © 2003, American Society for…